Mae’r cynnwys hwn wedi dod o wefan allanol ac mae ar gael yn Saesneg yn unig.
Deals, Treatments and Patients in the 20s
Building on the evolution of the past 19 years, Genesis 2020 will assemble senior executives and decision-makers from across the Life Science, Technology and Investment field to present, discuss and demonstrate their collective insight and thought leadership for the sector, themselves and their stakeholders.
In recent years, the structure of the industry, development of technologies and evolving role of patients have been transformational for the sector. Wider diversity in industry players involved, more convergence with the digital world and technology, the increasing strategic role played by data, better understanding of disease biology, to name a few are transforming the way our industry is funded, organised, valued and ultimately its outcome adopted.
For its 20th anniversary, Genesis will review key industry deals to provide insights on future years strategies and value chain development; will cover the tremendous progresses in ‘advanced therapeutics’ and the value they can bring to patients and the society as a whole as well as discussing the evolving role of patients at the centre of R&D.
Please visit the Genesis Digital 2020 website for more information and to register.